During this webinar, you will learn about NS Pharma, Inc. (a wholly owned, US subsidiary of Nippon Shinyaku Co., Ltd. based in Kyoto, Japan), focused on developing innovative treatments for rare diseases, including Duchenne muscular dystrophy (DMD). You will also learn about the patient support services available through NS Support – NS Pharma, Inc.’s program to assist patients and caregivers navigate access to infusion therapies, which may be complex for some patients.
Make an Impact
You can advance the care, treatment and cure for Duchenne muscular dystrophy. Contributions in any amount can truly make a difference and can be credited to a fundraiser or event from the list below.Donate